Validation of an automated viable cell counting assay for GMP manufacturing of human induced pluripotent stem cells
Authors:
- Valeria PeliVPValeria Peli
- Mario BarilaniMBMario Barilani
- Araceli Rivera-OrdazARAraceli Rivera-Ordaz
- Paolo ManziniPMPaolo Manzini
- Francesco RusconiFRFrancesco Rusconi
- Cristiana LavazzaCLCristiana Lavazza
- Silvia CimoniSCSilvia Cimoni
- Lorenza LazzariLorenza Lazzari
- 24 April 2023
- journal article
- research article
- Published by Elsevier in Biochemical Engineering Journal
- Vol. 196
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell LinesRegenerative Medicine, 2018
- Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell ProductionStem Cells International, 2018
- Biomanufacturing for clinically advanced cell therapiesNature Biomedical Engineering, 2018
- Summary of the National Institute of Standards and Technology and US Food And Drug Administration cell counting workshop: Sharing practices in cell counting measurementsCytotherapy, 2018
- Regenerative medicine: Clinical applications and future perspectivesJournal of Microscopy and Ultrastructure, 2017
- Defining quality attributes to enable measurement assurance for cell therapy productsCytotherapy, 2016
- Strategies for Achieving Measurement Assurance for Cell Therapy ProductsStem Cells Translational Medicine, 2016
- Validation of analytical methods in GMP: the disposable Fast Read 102® device, an alternative practical approach for cell countingJournal of Translational Medicine, 2012
- Induction of pluripotent stem cells from fibroblast culturesNature Protocols, 2007
- HPC viability measurement: trypan blue versus acridine orange and propidium iodideTransfusion, 2000